P-203 SLCG 9901: phase II trial with cisplatin (cis), gemcitabine (gem) and docetaxel (doc) as neoadjuvant treatment in stage IIIA N2 and T4N0-1 non-small cell lung cancer (NSCLC) patients

Abstract CT041: Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy

10.1158/1538-7445.am2019-ct041 ◽

2019 ◽

Author(s):

Peter Ordentlich ◽

Lei Wang ◽

David Tamang ◽

Amy H. Sullivan ◽

Sally E. Church ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Gene Signatures ◽

Randomised Phase II Trial of Oral Vinorelbine (N) and Cisplatin (P) or Pemetrexed and C (PC) in First Line Advanced Non Squamous (NSCC) Non Small Cell Lung Cancer (NSCLC) Patients (PTS). Navotrial01: Final Results

Annals of Oncology ◽

10.1016/s0923-7534(20)33841-2 ◽

2012 ◽

Vol 23 ◽

pp. ix409

Author(s):

E.H. Tan ◽

L. Havel ◽

M.J. Krzakowski ◽

J. Kollmeier ◽

R. Gervais ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

Cancer Gene Therapy ◽

10.1038/cgt.2009.15 ◽

2009 ◽

Vol 16 (8) ◽

pp. 620-624 ◽

Cited By ~ 87

Author(s):

J Nemunaitis ◽

M Nemunaitis ◽

N Senzer ◽

P Snitz ◽

C Bedell ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Tumor Vaccine ◽

Small Cell ◽

Small Cell Lung ◽

Antisense Gene ◽

Phase II Trial of Sequential Chemotherapy Followed by Chemoradiation, Surgery, and Postoperative Chemotherapy for the Treatment of Stage IIIA/IIIB Non-Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.3816/clc.2006.n.040 ◽

2006 ◽

Vol 8 (2) ◽

pp. 122-129 ◽

Author(s):

Prudence Lam ◽

Stuart Berman ◽

Robert Thurer ◽

Simon Ashiku ◽

Malcolm DeCamp ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Postoperative Chemotherapy ◽

Small Cell Lung ◽

Stage Iiia ◽

Sequential Chemotherapy

Docetaxel and cisplatin as induction chemotherapy in stage IIIA N2 non-small cell lung cancer (NSCLC): An EORTC phase II trial (08984)

10.1200/jco.2004.22.14_suppl.7166 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7166-7166 ◽

Cited By ~ 2

Author(s):

C. Manegold ◽

B. Biesma ◽

H. Smit ◽

J. Van Meerbeeck ◽

C. Debruyne ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia

Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A SWOG phase II trial (S0027)

10.1200/jco.2004.22.14_suppl.7056 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7056-7056 ◽

Cited By ~ 5

Author(s):

P. J. Hesketh ◽

K. Chansky ◽

D. H. Lau ◽

J. Crowley ◽

D. R. Gandara

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Small Cell ◽

Small Cell Lung ◽

Docetaxel and cisplatin as induction chemotherapy in stage IIIA N2 non-small cell lung cancer (NSCLC): An EORTC phase II trial (08984)

10.1200/jco.2004.22.90140.7166 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7166-7166 ◽

Cited By ~ 2

Author(s):

C. Manegold ◽

B. Biesma ◽

H. Smit ◽

J. Van Meerbeeck ◽

C. Debruyne ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia

SAKK 16/14: Anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm phase II trial.

10.1200/jco.2016.34.15_suppl.tps8573 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS8573-TPS8573 ◽

Author(s):

Sacha Rothschild ◽

Alfred Zippelius ◽

Spasenija Savic ◽

Michel Gonzalez ◽

Walter Weder ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia

Abstract CT041: Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy

10.1158/1538-7445.sabcs18-ct041 ◽

2019 ◽

Author(s):

Peter Ordentlich ◽

Lei Wang ◽

David Tamang ◽

Amy H. Sullivan ◽

Sally E. Church ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Gene Signatures ◽

O-033 Docetaxel (DOC), cisplatin (CIS) and gemcitabine (GEM) asneoadjuvant treatment in stage IIIAN2 and T4N0-1 non-small cell lung cancer (NSCLC) patients (P). final results of SLCG phase II trial 9901

Lung Cancer ◽

10.1016/s0169-5002(05)80165-5 ◽

2005 ◽

Vol 49 ◽

pp. S14 ◽

Author(s):

P. Garrido ◽

R. Rosell ◽

A. Torres ◽

J. González Larriba ◽

M. Provencio ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽